Northwest Biotherapeutics

(OTC) NWBO

Current Price$0.25

Market Cap$405.73M

Since IPO (2001)-100%

5 Year-85%

1 Year-12%

1 Month+26%

Northwest Biotherapeutics Financials at a Glance

Market Cap

$405.73M

Revenue (TTM)

$1.50M

Net Income (TTM)

$44.22M

EPS (TTM)

$-0.03

P/E Ratio

-5.89

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Price

$0.25

Volume

2,987,530

Open

$0.26

Price

$0.25

Volume

2,987,530

Open

$0.26

Previous Close

$0.25

Daily Range

$0.25 - $0.26

52-Week Range

$0.19 - $0.37

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Price

$0.25

Volume

2,987,530

Open

$0.26

Previous Close

$0.25

Daily Range

$0.25 - $0.26

52-Week Range

$0.19 - $0.37

NWBO News

Is Northwest Biotheraputics a Buy Ahead of Its Brain Tumor Vaccine Clinical Data Release?

Zhiyuan SunOct 28, 2020

Did Northwest Biotherapeutics Just Check Off 1 Box Needed for Its Stock to Double?

Zhiyuan SunMay 28, 2020

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Northwest Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Linda F. Powers

Website

www.nwbio.com

Headquarters

Bethesda, MD 20814, US

NWBO Financials

Key Financial Metrics (TTM)

Gross Margin

-21%

Operating Margin

-36%

Net Income Margin

-30%

Return on Equity

Return on Capital

18%

Return on Assets

-55%

Earnings Yield

-16.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$405.73M

Shares Outstanding

1.61B

Volume

2.99M

Avg. Volume

3.00M

Financials (TTM)

Gross Profit

$959.00K

Operating Income

$59.91M

EBITDA

$57.58M

Operating Cash Flow

$44.76M

Capital Expenditure

$1.50M

Free Cash Flow

$46.27M

Cash & ST Invst.

$3.04M

Total Debt

$64.83M

Northwest Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$494.00K

+31.7%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$405.73M

N/A

Market Cap/Employee

$16.23M

N/A

Employees

N/A

Net Income

$3.40M

+82.7%

EBITDA

$10.90M

+37.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$62.21M

+6.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$20.50M

-16.6%

Short Term Debt

$43.49M

-2.1%

Return on Assets

-55.24%

N/A

Return on Invested Capital

18.31%

N/A

Free Cash Flow

$12.51M

-32.8%

Operating Cash Flow

$12.51M

-32.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PTCHFPureTech Health plc

PTCHFPureTech Health plc$1.69+0.00%

CLVLYClinuvel Pharmaceuticals Limited

CLVLYClinuvel Pharmaceuticals Limited$6.84-0.21%

CYDYCytoDyn Inc.

CYDYCytoDyn Inc.$0.35-1.86%

CMVLFCellectis S.A.

CMVLFCellectis S.A.$3.08-30.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

INTCIntel

INTCIntel$108.77-0.06%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

FIGFigma

FIGFigma$22.92+0.13%

Questions About NWBO

What is the current price of Northwest Biotherapeutics?

Northwest Biotherapeutics is trading at $0.25 per share.

What is the 52-week range for Northwest Biotherapeutics?

Over the past 52 weeks, Northwest Biotherapeutics has traded between $0.19 and $0.37.

How much debt does Northwest Biotherapeutics have?

As of the most recent reporting period, Northwest Biotherapeutics reported total debt of $63.99M.

How much cash does Northwest Biotherapeutics have on hand?

Northwest Biotherapeutics reported $1.79M in cash and cash equivalents in its most recent financial results.

What is Northwest Biotherapeutics’s dividend yield?

Northwest Biotherapeutics does not currently have a dividend yield.

Northwest Biotherapeutics

Northwest Biotherapeutics Financials at a Glance

NWBO News

Is Northwest Biotheraputics a Buy Ahead of Its Brain Tumor Vaccine Clinical Data Release?

Did Northwest Biotherapeutics Just Check Off 1 Box Needed for Its Stock to Double?

Why Northwest Biotherapeutics, Accuray, and U.S. Steel Slumped Today

5 Stocks We're Staying Away From in 2016

3 Stocks I Would Avoid at All Costs

Why Shares of Northwest Biotherapeutics Inc Are Crashing Today

2 Biotech Stocks Wall Street Hates

This Illegal Drug Could Be the Answer to Fighting Brain Cancer

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Northwest Biotherapeutics

NWBO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Northwest Biotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NWBO

What is the current price of Northwest Biotherapeutics?

What is the 52-week range for Northwest Biotherapeutics?

How much debt does Northwest Biotherapeutics have?

How much cash does Northwest Biotherapeutics have on hand?

What is Northwest Biotherapeutics’s dividend yield?

Premium Investing Services